November 07, 2025

AI solutions from the DKFZ set new standards in medical image processing

AI solutions from the DKFZ set new standards in medical image processing

Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year’s world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support and follow-up care.

International competitions play a crucial role in advancing AI-based analysis of medical images. Similar to how new drugs are tested in randomized controlled trials, the competitions provide an objective and transparent framework for comparing and evaluating algorithmic solutions.

The competition winners were announced at this year’s MICCAI (Medical Image Computing and Computer Assisted Intervention) conference: In seven of the eight competitions in which DKFZ researchers participated, they achieved first place with their algorithms. These covered a broad spectrum of relevant oncological issues: from early detection (breast cancer on MRI images, detection of suspicious lesions in whole-body PET/CTs) to diagnostics (e.g., visualization of liver tumors in CT images and esophageal cancer in endoscopy images) to therapy support and follow-up care (prediction of treatment success in breast cancer, therapy planning for pancreatic cancer, reduction of the complication rate in gallbladder surgery).

“AI competitions of this kind are initiated by medical societies, for example, and selected by interdisciplinary expert groups in a review process,” explains AI expert Lena Maier-Hein from the DKFZ. All participants are evaluated using the same, previously unknown data sets. This enables a fair comparison of the methods and represents an important step in external validation. The aim is to test whether an algorithm that works well in a specific environment can also be transferred to new data and real clinical conditions. Such independent benchmarking procedures are an essential step on the path from academic innovation to clinical application.

“It was particularly challenging to achieve consistent results with our algorithms given the wide variety of imaging devices and clinical protocols from more than 50 clinics on six continents,” explains Amine Yamlahi, head of the team from Lena Maier-Hein’s division that won this year’s surgical Lighthouse Challenge. “We are proud of our teams! Their successes show that we combine cutting-edge AI research with outstanding AI engineering, putting us in the international top league,” says Klaus Maier-Hein, head of the DKFZ’s Medical Image Processing division.

The successes of the DKFZ teams underscore Germany’s impressive role in the development of reliable, generalizable, and clinically relevant AI. Every year, the international MICCAI competitions attract the world’s leading academic and industrial research groups and set standards for excellence in medical image processing.

The importance of such AI competitions is also demonstrated by the success story of the nnU-Net algorithm developed at the DKFZ in Klaus Maier-Hein’s division, which won the prestigious Medical Segmentation Decathlon Challenge in 2018. The publication of this self-learning algorithm, which automatically adapts to new medical imaging tasks, became one of the most cited DKFZ publications in recent years. After gaining widespread attention as the winner of an internationally recognized competition, nnU-Net has been integrated into numerous commercial and academic AI products. It is thus making an important contribution to the advancement of medical image analysis and is already benefiting patients.

Klaus Maier-Hein summarizes the successes: “The results of the MICCAI competitions in 2025 reinforce the DKFZ’s commitment to translating artificial intelligence into practical tools that improve the diagnosis and treatment of cancer.”

Our latest News

discover more
Prof. Gudrun Rappold receives medal of honor from the German Society for Human Genetics

Prof. Gudrun Rappold receives medal of honor from the German Society for Human Genetics

Prof. Dr. Gudrun Rappold, senior professor at Heidelberg University’s Medical Faculty, has been awarded the Medal of Honor by the German Society for Human Genetics. The Medal of Honor is the highest award given by the professional association and recognizes outstanding scientific achievements in human genetics as well as special contributions to the advancement of […]

How cancer immunotherapies affect the heart

How cancer immunotherapies affect the heart

The Hector Foundation is providing €1.3 million in funding for an interdisciplinary research project investigating the cardiological side effects of checkpoint inhibitors. The consortium, with partners at Heidelberg University’s Medical Faculty, the German Cancer Research Center, the Max Delbrück Center in Berlin, and the University Medical Center Schleswig-Holstein in Kiel, is investigating why these cancer […]

Early detection contributes to declining breast cancer mortality rates in Europe

Early detection contributes to declining breast cancer mortality rates in Europe

The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by one of the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the German Cancer Research Center (DKFZ). The most […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp